Evaluating the Effects of an Ophthalmic Solution of Coenzyme Q10 and Vitamin E in Open-Angle Glaucoma Patients: A Study Protocol

被引:0
作者
Luciano Quaranta
Ivano Riva
Elena Biagioli
Erica Rulli
Eliana Rulli
Davide Poli
Lorenzo Legramandi
机构
[1] University of Pavia,Department of Surgical & Clinical, Diagnostic and Pediatric Sciences, Section of Ophthalmology
[2] IRCCS Fondazione Policlinico San Matteo,Laboratory of Methodology for Clinical Research
[3] IRCCS – Fondazione Bietti,undefined
[4] Istituto di Ricerche Farmacologiche Mario Negri IRCCS,undefined
来源
Advances in Therapy | 2019年 / 36卷
关键词
Coenzyme Q10; Open-angle glaucoma; Ophthalmology; Prostaglandin analogue; Randomized clinical trial; Vitamin E;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2506 / 2514
页数:8
相关论文
共 121 条
[1]  
Goldberg I(1981)Optic disc and visual field changes in primary open angle glaucoma Aust J Ophthalmol 9 223-229
[2]  
Tham YC(2014)Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis Ophthalmology 121 2081-2090
[3]  
Li X(2006)The number of people with glaucoma worldwide in 2010 and 2020 Br J Ophthalmol 90 262-267
[4]  
Wong TY(1989)Intraocular pressure and glaucoma Am J Ophthalmol 107 186-188
[5]  
Quigley HA(2014)The pathophysiology and treatment of glaucoma: a review JAMA 311 1901-1911
[6]  
Aung T(2002)Reduction of intraocular pressure and glaucoma progression: results from the early manifest glaucoma trial Arch Ophthalmol 120 1268-1279
[7]  
Cheng CY(2000)The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. The AGIS Investigators Am J Ophthalmol 130 429-440
[8]  
Quigley HA(2009)Visual field progression in the Collaborative initial glaucoma treatment study the impact of treatment and other baseline factors Ophthalmology 116 200-207
[9]  
Broman AT(1998)The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma Am J Ophthalmol 126 498-505
[10]  
Sommer A(2012)Glaucoma 2.0: neuroprotection, neuroregeneration, neuroenhancement Ophthalmology 119 979-986